Viking Global Investors LP Bio N Tech Se Transaction History

Viking Global Investors LP

  • $31.6 Billion
  • Q2 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
SELL
$91.06 - $126.88 $5.54 Million - $7.72 Million
-60,878 Reduced 6.47%
879,972 $80.1 Million
Q4 2024

Feb 14, 2025
BUY
$99.72 - $122.68 $89.2 Million - $110 Million
894,556 Added 1932.34%
940,850 $107 Million
Q3 2024

Nov 14, 2024
BUY
$78.36 - $124.66 $3.63 Million - $5.77 Million
46,294 New
46,294 $5.5 Million

Others Institutions Holding BNTX

# of Institutions
320
Shares Held
40.9M
Call Options Held
1.38M
Put Options Held
1.52M
View Full List

About BioNTech SE

BNTX Quotes by TradingView
  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $24B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Viking Global Investors LP Portfolio

Follow Viking Global Investors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Viking Global Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Viking Global Investors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email